4.7 Review

Engineering versatile Au-based catalysts for solar-to-fuel conversion

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF

Jiang Li et al.

Summary: This study suggests that immune-metabolism disorder triggered by HBV exacerbation may be a potential mechanism of HBV-ACLF, providing a novel diagnostic and treatment target to reduce HBV-ACLF-related mortality.
Article Genetics & Heredity

A Five-Gene Signature Associated With DNA Damage Repair Molecular Subtype Predict Overall Survival for Hepatocellular Carcinoma

Junyu Huo et al.

Summary: The proposed five-gene risk score in this study may provide new insights into the individualized evaluation of HCC prognosis.

FRONTIERS IN GENETICS (2022)

Article Cardiac & Cardiovascular Systems

Osteopontin promotes infarct repair

Itai Rotem et al.

Summary: Understanding how macrophages promote myocardial repair can help create new therapies for infarct repair. Recombinant osteopontin (OPN) has been found to play a significant role in myocardial healing by stimulating cardiac cell growth, cell-cycle re-entry, and migration. OPN also promotes proliferation and migration of non-cardiomyocytes. In animal models, OPN injection improves scar formation, cardiac function, and left ventricular remodeling. OPN may serve as a promising cell-free therapy for optimizing infarct repair.

BASIC RESEARCH IN CARDIOLOGY (2022)

Review Gastroenterology & Hepatology

Osteopontin Takes Center Stage in Chronic Liver Disease

Zhuolun Song et al.

Summary: Despite being initially discovered in bone, osteopontin (OPN) is expressed in other tissues as well. In addition to its well-established physiological roles, research suggests that OPN is also involved in chronic liver disease.

HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Assessing the role of amino acids in systemic inflammation and organ failure in patients with ACLF

Giacomo Zaccherini et al.

Summary: In patients with ACLF, metabolite modules increased along with markers of systemic inflammation and oxidative stress. Most proteinogenic amino acids were present and increased. A metabolic network involving amino acids was activated, suggesting increased nucleotide synthesis. Certain compounds involved in antioxidant synthesis were increased. Intermediates of ketogenic amino acids catabolism were increased. Levels of spermidine, an autophagy inducer, were decreased.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

Jonel Trebicka et al.

Summary: This study analyzed the precipitants leading to acute decompensation in cirrhosis patients, identifying proven bacterial infections and severe alcoholic hepatitis as the main causes. The number of precipitants was significantly associated with 90-day mortality, emphasizing the need for specific preventive and therapeutic strategies targeting these events.

JOURNAL OF HEPATOLOGY (2021)

Article Immunology

Increased Circulating T Follicular Helper Cells Induced via IL-12/21 in Patients With Acute on Chronic Hepatitis B Liver Failure

Bingying Du et al.

Summary: The study found that the frequency of T follicular helper (Tfh) cells significantly increased in HBV-ACLF patients, correlating with MELD score. Additionally, HBV-ACLF patients had higher serum levels of IL-12 and IL-21. Naive CD4(+) T cells from healthy controls differentiated into Tfh cells when exposed to serum from HBV-ACLF patients.

FRONTIERS IN IMMUNOLOGY (2021)

Review Gastroenterology & Hepatology

Acute-on-chronic liver failure: A distinct clinical syndrome

Richard Moreau et al.

Summary: ACLF has different operating definitions in different geographic regions, with Western countries focusing on patients with cirrhosis and Asia focusing on patients with chronic liver diseases. ACLF can be precipitated by different acute insults and defined by different consortia, but all agree that it is a distinct clinical entity.

JOURNAL OF HEPATOLOGY (2021)

Article Medicine, Research & Experimental

Plasminogen as a prognostic biomarker for HBV-related acute-on-chronic liver failure

Daxian Wu et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Immunology

Metabolic modulation of acetaminophen-induced hepatotoxicity by osteopontin

Yankai Wen et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2019)

Review Gastroenterology & Hepatology

Novel perspectives in the management of decompensated cirrhosis

Mauro Bernardi et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis

Mark J. W. McPhail et al.

JOURNAL OF HEPATOLOGY (2016)

Article Medicine, General & Internal

Acute-on-chronic liver failure in cirrhosis

Vicente Arroyo et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Article Biochemistry & Molecular Biology

Plasma osteopontin in acute liver failure

Praveen Srungaram et al.

CYTOKINE (2015)

Article Gastroenterology & Hepatology

Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis

Thierry Gustot et al.

HEPATOLOGY (2015)

Review Gastroenterology & Hepatology

Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis

Vicente Arroyo et al.

JOURNAL OF HEPATOLOGY (2015)

Article Medicine, General & Internal

Acute-on-chronic liver failure

William Bernal et al.

LANCET (2015)

Article Gastroenterology & Hepatology

Osteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation

Devanshi Seth et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Review Multidisciplinary Sciences

Disease Tolerance as a Defense Strategy

Ruslan Medzhitov et al.

SCIENCE (2012)

Article Immunology

Involvement of Th17 and Th1 Effector Responses in Patients with Hepatitis B

Yufu Ye et al.

JOURNAL OF CLINICAL IMMUNOLOGY (2010)

Article Gastroenterology & Hepatology

A model to predict survival in patients with end-stage liver disease

PS Kamath et al.

HEPATOLOGY (2001)